{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:56:59Z","timestamp":1788573419551,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["nmcd-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.numecd.2016.01.011","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T19:29:56Z","timestamp":1460662196000},"page":"623-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Insulin resistance, postprandial GLP-1 and adaptive immunity are the main predictors of NAFLD in a homogeneous population at high cardiovascular risk"],"prefix":"10.1016","volume":"26","author":[{"given":"L.","family":"Bozzetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Annuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ragucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Di Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Della Pepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Della Corte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Griffo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Anniballi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Giacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Rivellese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.numecd.2016.01.011_bib1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.numecd.2007.01.007","article-title":"Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question","volume":"17","author":"Loria","year":"2007","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5","key":"10.1016\/j.numecd.2016.01.011_bib2","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/nu5051544","article-title":"Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"Gaggini","year":"2013","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.numecd.2016.01.011_bib3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.clnu.2013.11.003","article-title":"Diets and nonalcoholic fatty liver disease: the good and the bad","volume":"33","author":"Asrih","year":"2014","journal-title":"Clin Nutr"},{"issue":"8","key":"10.1016\/j.numecd.2016.01.011_bib4","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nrendo.2011.72","article-title":"Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment","volume":"7","author":"Smith","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10.1016\/j.numecd.2016.01.011_bib5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/hep.20920","article-title":"Insulin resistance: a metabolic pathway to chronic liver disease","volume":"42","author":"Bugianesi","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.numecd.2016.01.011_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2362.2010.02372.x","article-title":"Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution","volume":"41","author":"Bozzetto","year":"2011","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1016\/j.numecd.2016.01.011_bib7","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.metabol.2008.09.013","article-title":"Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response","volume":"58","author":"Rijkelijkhuizen","year":"2009","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.numecd.2016.01.011_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1758-5996-6-43","article-title":"Liver fat accumulation is associated with reduced hepatic insulin extraction and beta cell dysfunction in healthy older individuals","volume":"6","author":"Finucane","year":"2014","journal-title":"Diabetol Metab Syndr"},{"issue":"4","key":"10.1016\/j.numecd.2016.01.011_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1530\/EJE-13-0487","article-title":"Preserved GLP-1 and exaggerated GIP secretion in type 2 diabetes and relationships with triglycerides and ALT","volume":"169","author":"Alssema","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.numecd.2016.01.011_bib10","doi-asserted-by":"crossref","first-page":"e50117","DOI":"10.1371\/journal.pone.0050117","article-title":"Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists","volume":"7","author":"Cuthbertson","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.numecd.2016.01.011_bib11","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1210\/jc.2007-0187","article-title":"Postprandial lipemia associates with liver fat content","volume":"92","author":"Matikainen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.numecd.2016.01.011_bib12","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.numecd.2016.01.011_bib13","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"issue":"25","key":"10.1016\/j.numecd.2016.01.011_bib14","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.numecd.2016.01.011_bib15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3945\/ajcn.113.073445","article-title":"Diets naturally rich in polyphenols improve fasting and postprandial dyslipidemia and reduce oxidative stress: a randomized controlled trial","volume":"99","author":"Annuzzi","year":"2014","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"10.1016\/j.numecd.2016.01.011_bib16","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.metabol.2009.05.032","article-title":"Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with (1)H magnetic resonance spectroscopy","volume":"58","author":"Mancini","year":"2009","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.numecd.2016.01.011_bib17","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1210\/jc.2003-031764","article-title":"Exogenous and endogenous postprandial lipid abnormalities in type 2 diabetic patients with optimal blood glucose control and optimal fasting triglyceride levels","volume":"89","author":"Rivellese","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"17\u201318","key":"10.1016\/j.numecd.2016.01.011_bib18","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.cca.2011.05.011","article-title":"Active glucagon-like peptide-1 (GLP-1): storage of human plasma and stability over time","volume":"412","author":"Di Marino","year":"2011","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.numecd.2016.01.011_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1521-690X(03)00042-3","article-title":"Methods for clinical assessment of insulin sensitivity and beta-cell function","volume":"17","author":"Pacini","year":"2003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.numecd.2016.01.011_bib20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.gastro.2008.03.021","article-title":"Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes","volume":"135","author":"Kotronen","year":"2008","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.numecd.2016.01.011_bib21","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.numecd.2016.01.011_bib22","doi-asserted-by":"crossref","first-page":"e94059","DOI":"10.1371\/journal.pone.0094059","article-title":"Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance","volume":"9","author":"Kahl","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.numecd.2016.01.011_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0032-1306423","article-title":"Dyslipidemia in patients with nonalcoholic fatty liver disease","volume":"32","author":"Chatrath","year":"2012","journal-title":"Semin Liver Dis"},{"issue":"11","key":"10.1016\/j.numecd.2016.01.011_bib24","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1210\/jc.2014-2365","article-title":"Interrelationships between the kinetics of VLDL subspecies and HDL catabolism in abdominal obesity: a multicenter tracer kinetic study","volume":"99","author":"Verg\u00e8s","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.numecd.2016.01.011_bib25","doi-asserted-by":"crossref","first-page":"e87488","DOI":"10.1371\/journal.pone.0087488","article-title":"Glucose-induced glucagon-like peptide 1 secretion is deficient in patients with non- alcoholic fatty liver disease","volume":"9","author":"Bernsmeier","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.numecd.2016.01.011_bib26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/jdi.12065","article-title":"Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: incretin actions beyond the pancreas","volume":"4","author":"Seino","year":"2013","journal-title":"J Diabetes Invest"},{"issue":"6","key":"10.1016\/j.numecd.2016.01.011_bib27","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1161\/ATVBAHA.112.246207","article-title":"Exenatide, a glucagon-like peptide-1 receptor agonist, acutely inhibits intestinal lipoprotein production in healthy humans","volume":"32","author":"Xiao","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.numecd.2016.01.011_bib28","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1530\/JOE-13-0201","article-title":"Inflammation as a potential link between non-alcoholic fatty liver disease and insulin resistance","volume":"218","author":"Asrih","year":"2013","journal-title":"J Endocrinol"},{"issue":"10","key":"10.1016\/j.numecd.2016.01.011_bib29","doi-asserted-by":"crossref","first-page":"19867","DOI":"10.3390\/ijms141019867","article-title":"Immunological mechanisms in the pathophysiology of non-alcoholic steatohepatitis","volume":"14","author":"Vonghia","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.numecd.2016.01.011_bib30","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/hep.26955","article-title":"Does interleukin-17 play the villain in non-alcoholic steatohepatitis?","volume":"59","author":"Kisseleva","year":"2014","journal-title":"Hepatology"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475315300478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475315300478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T14:38:25Z","timestamp":1567780705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475315300478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0939475315300478"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2016.01.011","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin resistance, postprandial GLP-1 and adaptive immunity are the main predictors of NAFLD in a homogeneous population at high cardiovascular risk","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2016.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}